Compass Pathways PLC CMPS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
7.99quote price arrow down-0.29 (-3.50%)
Volume
240,563
52 week range
5.01 - 12.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.99
  • 52 Week High12.75
  • 52 Week High Date02/28/24
  • 52 Week Low5.01
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap546.363M
  • Shares Out68.38M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta2.35
  • YTD % Change-8.69

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.99
  • 52 Week High12.75
  • 52 Week High Date02/28/24
  • 52 Week Low5.01
  • 52 Week Low Date11/13/23
  • Market Cap546.363M
  • Shares Out68.38M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta2.35
  • YTD % Change-8.69

RATIOS/PROFITABILITY

  • EPS (TTM)-2.37
  • P/E (TTM)-3.38
  • Fwd P/E (NTM)-3.81
  • EBITDA (TTM)-133.394M
  • ROE (TTM)-61.52%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)11.22%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Compass Pathways PLC

 

Profile

MORE
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline...
David Norton
Interim Independent Chairman of the Board
Kabir Nath
Chief Executive Officer, Executive Director
Teri Loxam
Chief Financial Officer, Principal Accounting Officer
Matthew Owens
General Counsel, Chief Legal Officer
Address
3Rd Floor, 1 Ashley Road
Altrincham
WA14 2DT
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
ATXS
Astria Therapeutics Inc
9.43+0.16+1.73%
CABA
Cabaletta Bio Inc
12.62-0.07-0.55%
OLMA
Olema Pharmaceuticals Inc
9.66-0.19-1.93%
IGMS
IGM Biosciences Inc
9.29-0.20-2.11%
CELC
Celcuity Inc
17.66+0.43+2.50%